Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]

Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]

Yoshiyo Oguchi Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Japan Correspondence: Yoshiyo Oguchi, Department of Neuropsychiatry, St. Marianna University School of Medicine, 2-16-1, Sugao Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan, Tel/Fax +81-44-977-8111...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychiatric disease and treatment 2022-01, Vol.18, p.2979-2980
1. Verfasser: Oguchi, Yoshiyo
Format: Artikel
Sprache:eng
Schlagworte:
Antipsychotics
Coronaviruses
COVID-19
Letter
Medication adherence
Mental disorders
Pandemics
Patient compliance
Psychiatrists
Psychotropic drugs
Schizophrenia
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Yoshiyo Oguchi Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Japan Correspondence: Yoshiyo Oguchi, Department of Neuropsychiatry, St. Marianna University School of Medicine, 2-16-1, Sugao Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan, Tel/Fax +81-44-977-8111 Ext. 3202-3205 ; +81-44-976-3341, Email [email protected] View the original paper by Ms Zhdanava and colleagues
ISSN:1176-6328
1178-2021
1178-2021
DOI:10.2147/NDT.S399627